537 related articles for article (PubMed ID: 17667546)
1. Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas.
Ip PP; Lam KW; Cheung CL; Yeung MC; Pun TC; Chan QK; Cheung AN
Am J Surg Pathol; 2007 Aug; 31(8):1215-24. PubMed ID: 17667546
[TBL] [Abstract][Full Text] [Related]
2. Unusual morphological features of uterine leiomyomas treated with progestogens.
Boyd C; McCluggage WG
J Clin Pathol; 2011 Jun; 64(6):485-9. PubMed ID: 21398323
[TBL] [Abstract][Full Text] [Related]
3. Uterine artery blood flow parameters in women with dysfunctional uterine bleeding and uterine fibroids: the effects of tranexamic acid.
Lakhani KP; Marsh MS; Purcell W; Hardiman P
Ultrasound Obstet Gynecol; 1998 Apr; 11(4):283-5. PubMed ID: 9618854
[TBL] [Abstract][Full Text] [Related]
4. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Magalhães J; Aldrighi JM; de Lima GR
Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
[TBL] [Abstract][Full Text] [Related]
5. The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database.
Sundström A; Seaman H; Kieler H; Alfredsson L
BJOG; 2009 Jan; 116(1):91-7. PubMed ID: 19016686
[TBL] [Abstract][Full Text] [Related]
6. Apoplectic leiomyomas of the uterus. A clinicopathologic study of five distinctive hemorrhagic leiomyomas associated with oral contraceptive usage.
Myles JL; Hart WR
Am J Surg Pathol; 1985 Nov; 9(11):798-805. PubMed ID: 4073354
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral Vasculopathy in Leiomyoma Treated With Tranexamic Acid.
Kudose S; Krigman HR
Int J Gynecol Pathol; 2017 Jul; 36(4):364-368. PubMed ID: 27801754
[TBL] [Abstract][Full Text] [Related]
8. Uterine smooth muscle tumors of uncertain malignant potential and atypical leiomyoma: a morphological study of these grey zones with clinical correlation.
Deodhar KK; Goyal P; Rekhi B; Menon S; Maheshwari A; Kerkar R; Tongaonkar HB
Indian J Pathol Microbiol; 2011; 54(4):706-11. PubMed ID: 22234095
[TBL] [Abstract][Full Text] [Related]
9. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
10. Uterine artery embolization with trisacryl gelatin microspheres in women treated for leiomyomas: a clinicopathologic analysis of alterations in gynecologic surgical specimens.
Maleki Z; Kim HS; Thonse VR; Judson K; Vinh TN; Vang R
Int J Gynecol Pathol; 2010 May; 29(3):260-8. PubMed ID: 20407327
[TBL] [Abstract][Full Text] [Related]
11. Bleeding associated with uterine leiomyomas. Tailor treatment to the individual patient.
Prescrire Int; 2014 May; 23(149):130-5. PubMed ID: 24926520
[TBL] [Abstract][Full Text] [Related]
12. Pathological findings associated with the presence of a mirena intrauterine system at hysterectomy.
Rizkalla HF; Higgins M; Kelehan P; O'Herlihy C
Int J Gynecol Pathol; 2008 Jan; 27(1):74-8. PubMed ID: 18156979
[TBL] [Abstract][Full Text] [Related]
13. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases.
Bell SW; Kempson RL; Hendrickson MR
Am J Surg Pathol; 1994 Jun; 18(6):535-58. PubMed ID: 8179071
[TBL] [Abstract][Full Text] [Related]
14. Tranexamic acid and thrombosis.
Prescrire Int; 2013 Jul; 22(140):182-3. PubMed ID: 23951593
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
16. The medical management of abnormal uterine bleeding in reproductive-aged women.
Bradley LD; Gueye NA
Am J Obstet Gynecol; 2016 Jan; 214(1):31-44. PubMed ID: 26254516
[TBL] [Abstract][Full Text] [Related]
17. Antifibrinolytics in women with menorrhagia.
Philipp CS
Thromb Res; 2011 Feb; 127 Suppl 3():S113-5. PubMed ID: 21262428
[TBL] [Abstract][Full Text] [Related]
18. The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study.
Gunes M; Ozdegirmenci O; Kayikcioglu F; Haberal A; Kaplan M
J Minim Invasive Gynecol; 2008; 15(6):735-8. PubMed ID: 18971138
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of oral tranexamic acid in women with heavy menstrual bleeding and fibroids.
Eder S; Baker J; Gersten J; Mabey RG; Adomako TL
Womens Health (Lond); 2013 Jul; 9(4):397-403. PubMed ID: 23656203
[TBL] [Abstract][Full Text] [Related]
20. Association between magnetic resonance imaging findings of uterine leiomyomas and symptoms demanding treatment.
Ruuskanen AJ; Hippeläinen MI; Sipola P; Manninen HI
Eur J Radiol; 2012 Aug; 81(8):1957-64. PubMed ID: 21592711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
